The Importance Of Flexible Technologies And Category Expertise In Cardiovascular Research

Despite advances in treatments and therapeutics, heart disease continues to be the leading cause of death in the United States and worldwide. Approximately one in five deaths, or nearly 700,000 people, in the U.S. are a result of heart disease, according to the CDC.

Thankfully, advances in medicine are leading to the development of new life-saving treatments, which have reduced the risk or morbidity of heart disease. This article highlights the importance of cardiovascular studies, where comprehensive and flexible EDC technologies play a crucial role in adapting to evolving study requirements. The iMednet platform is a perfect example of such a technology, as it proves itself instrumental in capturing detailed information that is essential for cardiovascular studies. However, technology is only part of the equation - having a valuable partner who understands the unique nuances and requirements of cardiovascular studies is critical to success.